Glipizide and Bactroban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Bactroban (mupirocin). Common drug interactions include bradycardia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Bactroban. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.



On Jul, 12, 2026

90 people who take Glipizide and Bactroban together, and have interactions are studied.

Glipizide and Bactroban drug interactions.

What are the common drug interactions of Glipizide and Bactroban, by gender? *:

female:

  1. Bradycardia (abnormally slow heart action)
  2. Depression
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Pain
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Urinary tract infection
  10. Abdominal pain

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Hypertension (high blood pressure)
  4. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  5. Dizziness
  6. Multiple injuries
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Weight increased
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Glipizide and Bactroban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Blood sodium decreased
  3. Cyst (a closed sac)
  4. Pneumonia

30-39:

  1. Asthma
  2. Cataract (clouding of the lens inside the eye)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Memory impairment

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Cardiac arrest
  5. Attention deficit/hyperactivity disorder
  6. Chest discomfort
  7. Depression
  8. Ear pain
  9. Facial pain
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

50-59:

  1. Erectile dysfunction
  2. Gynaecomastia (enlargement of the gland tissue of the male breast)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Prostatism (symptom complex resulting from compression or obstruction of the urethra, due most commonly to nodular hyperplasia of the prostate)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)
  7. Tricuspid valve incompetence (inefficient heart valve)
  8. Weight decreased
  9. Weight increased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Pain
  4. Pleural effusion (water on the lungs)
  5. Cough
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Atrioventricular block first degree (heart block first degree)
  9. Cardiac arrest
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 27 people, 30.00%
  2. Pain: 16 people, 17.78%
  3. High Blood Pressure: 15 people, 16.67%
  4. High Blood Cholesterol: 15 people, 16.67%
  5. Stress And Anxiety: 8 people, 8.89%
  6. Type 2 Diabetes: 7 people, 7.78%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 7.78%
  8. Gout (uric acid crystals building up in the body): 6 people, 6.67%
  9. Depression: 6 people, 6.67%
  10. Multiple Allergies (allergy to multiple agents): 5 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Bactroban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glipizide and Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glipizide and mupirocin (the active ingredients of Glipizide and Bactroban, respectively), and Glipizide and Bactroban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: